摘要
BACKGROUND: Previous studies have shown that PRDX1 is upregulated in some types of malignant tumors. The role of PRDX1 in non-smallcancer lung carcinoma (NSCLC) remains unclear. This study aims to identify the role of PRDX1 in influencing in-vitro biological functions of NSCLC and the molecular mechanism. @@@ METHODS: We collected 50 cases of fresh NSCLC and adjacent non-tumoral tissues for detecting differential expressions of PRDX1 by quantitative real-time polymerase chain reaction (qRT-PCR). Survival time of NSCLC patients, defined as the period from the operation to the latest follow-up or death due to recurrence or metastasis, was recorded for assessing the relationship between PRDX1 and prognosis in NSCLC. Using lentivirus transfection, PRDX1 level was downregulated in NSCLC cells. Subsequently, proliferative and apoptotic abilities, and expression levels of vital genes in the Wnt/beta-Catenin signaling were examined. Finally, the significance of activated Wnt/beta-Catenin signaling during PRDX1-regulated NSCLC proliferation was explored. @@@ RESULTS: Using GEPIA database and NSCLC tissues we collected, PRDX1 was detected to be upregulated in NSCLC samples than controls. PRDX1 level was related to tumor staging and prognosis in NSCLC. Knockdown of PRDX1 attenuated proliferative ability and stimulated apoptosis in NSCLC. Protein levels of Wnt5A was downregulated in H1299 and SPC-A1 cells with PRDX1 knockdown. Overexpression of beta-Catenin enhanced proliferative ability and inhibited apoptosis in NSCLC cells with PRDX1 knockdown. @@@ CONCLUSIONS: PRDX1 is upregulated in NSCLC samples, and linked to tumor staging and prognosis. It stimulates NSCLC to proliferate by activating the Wnt/beta-Catenin signaling.
学科与关键词
- SNX-2112 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Non-Small Cell Lung Cancer by Downregulating Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling PathwayCheng, Xiaozhen; Qin, Lingyu; Deng, Lian; Zhu, Xiongjie; Li, Ying; Wu, Xiaoran; Zheng, Yanfang*American Journal of Cancer Research, 2021, 12(19): 5825-5837.被引 4
- Metastatic Tumor Cell-Specific FABP7 Promotes NSCLC Metastasis via Inhibiting β-Catenin DegradationBai, Qiaorui; Yang, Xia; Li, Quanfeng; Chen, Weizhong; Tian, Han; Lian, Rong; Liu, Ximeng; Wang, Shuang; Yang, Yi*Cells, 2022, 11(5): 805.被引 2
- Upregulation of ADAMDEC1 correlates with tumor progression and predicts poor prognosis in non-small cell lung cancer (NSCLC) via the PI3K/AKT pathwayZhu, Weiliang; Shi, Lin; Gong, Yuxin; Zhuo, Lin; Wang, Siyun; Chen, Shaobing; Zhang, Bei*; Ke, Bin*Thoracic Cancer, 2022, 13(7): 1027-1039.被引 8
